| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human TRAF3IP1 recombinant protein (Position: L52-R691) was used as the immunogen for the TRAF3IP1 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
TRAF3IP1 Antibody / TRAF3-interacting protein 1 is an antibody targeting TRAF3IP1. Host: Rabbit. Polyclonal. Format: Lyophilized. Applications: WB, FACS, ELISA.
Key elements and design rationale
- Target: TRAF3IP1.
- Immunogen: E.coli-derived human TRAF3IP1 recombinant protein (Position: L52-R691) was used as the immunogen for the TRAF3IP1 antib….
- Species reactivity: Human, Mouse, Rat.
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
TRAF3IP1 antibody detects TRAF3-interacting protein 1, encoded by the TRAF3IP1 gene on chromosome 2q37.3. TRAF3IP1 antibody is widely used in research on ciliogenesis, vesicle transport, and signaling pathways.
Common research applications
- WB: relative abundance and band pattern assessment using appropriate controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
